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Resistance to 5-flucytosine (5-FC), used as an antifungal drug in combination therapy,
compromises its therapeutic action. In this work, the response of the human pathogen
Candida glabrata to 5-FC was evaluated at the membrane proteome level, using
an iTRAQ-based approach. A total of 32 proteins were found to display significant
expression changes in the membrane fraction of cells upon exposure to 5-FC, 50%
of which under the control of CgPdr1, the major regulator of azole drug resistance.
These proteins cluster into functional groups associated to cell wall assembly, lipid
metabolism, amino acid/nucleotide metabolism, ribosome components and translation
machinery, mitochondrial function, glucose metabolism, and multidrug resistance
transport. Given the obtained indications, the function of the drug:H+ antiporters
CgFlr1 (ORF CAGL0H06017g) and CgFlr2 (ORF CAGL0H06039g) was evaluated. The
expression of both proteins, localized to the plasma membrane, was found to confer
flucytosine resistance. CgFlr2 further confers azole drug resistance. The deletion of
CgFLR1 or CgFLR2 was seen to increase the intracellular accumulation of 5-FC, or 5-FC
and clotrimazole, suggesting that these transporters play direct roles in drug extrusion.
The expression of CgFLR1 and CgFLR2 was found to be controlled by the transcription
factors CgPdr1 and CgYap1, major regulator of oxidative stress resistance.
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INTRODUCTION
Systemic fungal infections are a problem of increasing clinical significance, especially since the
prophylactic and therapeutic use of antifungal drugs has led to an increased number of infections
with drug resistant fungal pathogens (Fidel et al., 1999; Mishra et al., 2007).
The antifungal drug 5-flucytosine (5-FC) is a fluorinated pyrimidine which enters fungal cells
through permeases (Ghannoum and Rice, 1999; Hope et al., 2004; Edlind and Katiyar, 2010) and
is then converted, by cytosine deaminase, to its metabolically active form 5-fluorouracil (5-FU)
(Ghannoum and Rice, 1999; Espinel-Ingroff, 2008; Edlind and Katiyar, 2010). This antifungal drug
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acts by inhibiting transcription, DNA replication and protein
synthesis (Ghannoum and Rice, 1999; Espinel-Ingroff, 2008). The
specificity of this antimycotic relies on the absence of cytosine
deaminase in mammalian cells (Hope et al., 2004; Edlind and
Katiyar, 2010). However, 5-FU is considered toxic, mostly due
to the conversion of flucytosine to fluorouracil by gut bacteria
(Vermes et al., 2000). Despite these side-effects, 5-FC is still used
clinically, mostly in combination therapy (Espinel-Ingroff, 2008).
Resistance to 5-FC in clinically relevant Candida species
develops rapidly under treatment (Sanglard and Odds, 2002).
Resistance is often related to decreased drug uptake by the
Fcy2 cytosine permease or decreased conversion of 5-FC to 5-
FU or 5-FUMP by the Fcy1 and Fur1 enzymes (Kontoyiannis
and Lewis, 2002; Papon et al., 2007; Espinel-Ingroff, 2008).
Some epidemiological studies suggest, however, that resistance
mechanisms, independent of the Fcy2-Fcy1-Fur1 pathway, may
play an important role in this phenomenon (Zhang et al., 2002).
For example, reduction of 5-FC intracellular accumulation,
mediated by the Drug:H+ Antiporter (DHA) CgAqr1 (Costa
et al., 2013a), or by the acquaglyceroporins CgFps1 and CgFps2
(Costa et al., 2015) were recently registered.
Given these observations, in this study the Candida glabrata
response to 5-FC was analyzed at the membrane proteome level,
using an iTRAQ-based approach. Among the obtained results,
the concentration of the DHA transporter CgFlr1 was seen to
increase in 5-FC challenged cells. The role of CgFlr1 (ORF
CAGL0H06017g), and of its very close homolog CgFlr2 (ORF
CAGL0H06039g) (Gbelska et al., 2006; Costa et al., 2014a), in the
resistance to 5-FC was then analyzed.
The deletion of CgFLR1 had been found to lead to increased
susceptibility to benomyl, diamide, and menadione, but not
to fluconazole (Chen et al., 2007). As for CgFlr2, it remained
uncharacterized until this study (Costa et al., 2014a). Both
proteins, however, are close homologs of the Saccharomyces
cerevisiae Flr1 DHA transporter. Flr1 confers resistance to many
unrelated chemical compounds as reviewed in Sá-Correia et al.
(2009), its expression being highly responsive to chemical stress
exposure (Brôco et al., 1999; Teixeira et al., 2008, 2010; Sá-
Correia et al., 2009; Dos Santos et al., 2014). The FLR1 homolog
in Candida albicans, MDR1, has been one of the few DHA
transporters linked so far to azole drug resistance (White, 1997;
Alarco and Raymond, 1999; Costa et al., 2013a,b, 2014a,b), being
an important determinant of clinical acquisition of resistance
against these antifungals (White, 1997; Alarco and Raymond,
1999; Costa et al., 2014a). These previous findings were used to
guide the functional analysis of CgFlr1 and CgFlr2 in this study,
in which the sub-cellular localization, role in antifungal drug
resistance, and expression analysis was carried out.
MATERIALS AND METHODS
Strains and Growth Media
C. glabrata parental strain KUE100 (Ueno et al., 2007)
and derived single deletion mutants KUE100_∆cgflr1 or
KUE100_∆cgflr2, constructed in this study, as well as the
C. glabrata strains 66032u and 66032u_∆cgpdr1 (Vermitsky
and Edlind, 2004), provided by Thomas Edlind, from Drexel
University, College of Medicine, Philadelphia, PA, were
batch-cultured at 30◦C, with orbital agitation (250 rpm)
in basal medium (BM), with the following composition
(per liter): 1.7 g yeast nitrogen base without amino acids or
NH4+ (Difco), 20 g glucose (Merck) and 2.65 g (NH4)2SO4
(Merck). C. glabrata strains L5U1 (cgura3∆0, cgleu2∆0),
84u (cgura3∆0), and 84u_∆cgyap1, kindly provided by John
Bennett, (Chen et al., 2007) from the National Institute of
Allergy and Infectious Diseases, NIH, Bethesda, USA, were
grown in BM medium supplemented with 20 mg/L uracil and
60mg/L leucine. S. cerevisiae parental strain BY4741 (MATa,
ura3∆0, leu2∆0, his3∆1, met15∆0) and the derived single
deletion mutant BY4741_∆flr1 were obtained from Euroscarf
(http://web.uni-frankfurt.de/fb15/mikro/euroscarf/). Cells were
batch-cultured at 30◦C, with orbital agitation (250 rpm) in
supplemented with 20mg/L methionine, 20mg/L histidine,
60mg/L leucine, 20mg/L uracil (all from Sigma). Solid media
contained, besides the above-indicated ingredients, 20 g/L agar
(Iberagar). The plasmid pGREG576 was obtained from the
Drag&Drop collection (Jansen et al., 2005).
Membrane Proteome-Wide Analysis of
C. glabrata Response to 5-Flucytosine
Exponentially growing wild-type 66032 C. glabrata strain and
the derived 66032_∆cgpdr1 deletion mutant were transferred to
fresh BM medium in the absence of stress (control conditions)
or in the presence of 4µg/mL 5-flucytosine (Sigma). Upon
1 h of cultivation, cells were harvested by centrifugation and
the membrane protein fraction was obtained as described
before (Pais et al., 2016). Expression proteomics analysis of the
obtained membrane-enriched fraction was carried out using an
iTRAQ-MS procedure, carried out as a paid service at the Keck
Foundation Biotechnology Resource Laboratory, Yale University,
USA (http://medicine.yale.edu/keck/proteomics/index.aspx),
using the method followed in Pais et al. (2016). Briefly, samples
were sonicated and proteins reduced by adding 50mM TCEP
(tris(2-carboxyethyl)phosphine), followed by 200mM MMTS
(methyl methane thiosulfonate). Protein digestion was achieved
by adding 10µL of a solution of 1mg/mL Lys-C, followed
by incubation at 37◦C for 3 h, and 10µL of 1mg/mL trypsin,
followed by overnight incubation at 37◦C. Macro-spin desalt of
the digests with C18 spin columns for cleanup and quantitation
was carried out, followed by dissolution in 65µL of 500mM
TEAB. iTRAQ labeling was carried out based on the AAA quant
protocol. iTRAQ experiments were carried out through the SCX
cartridge and experiments run on 5600.
The search parameters and acceptance criteria used were
the following: Peaklist generating software: ProteinPilot 4.5 and
Mascot; Search engine: Paragon Search Engine (ProteinPilot
4.2); Sequence Database/spectral library: C. glabrata [5478] from
SwissProt (May 2013); The database used was downloaded from
UniProt, with a total of 5197 protein entries. Mass spectrometric
analysis is done on an AB SCIEX TripleTOF R© 5600 mass
spectrometer with AB SCIEX ProteinPilotTM software used for
protein identification and quantitation. ProteinPilot utilizes a
ParagonTM algorithm with hybrid sequence tag and feature
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probability database searches. Hence, specific details such as
mass tolerances, specific modifications etc., are not utilized. All
iTRAQ results are uploaded into the Yale Protein Expression
database (YPED) for investigator viewing. Protein identification
was considered reliable for a Protein Score >2, corresponding
to a confidence level of 99%. A reserve decoy database search,
followed by filtering of all peptides above 1% False Discovery Rate
was carried out before protein grouping.
Proteomics data analysis started from 3 iTRAQ sets. The
samples present in each of the sets were randomized to prevent
bias, and in different sets distinct labels were used to tag
the samples, ensuring that protein identification in the MS
step is not biased by the tags. For each sample in a given
set, protein quantification was only considered for p < 0.05.
Protein expression changes above 1.5-fold or below 0.66-fold
were considered relevant. Protein classification into functional
groups was achieved based on their predicted function, according
to the Candida Genome Database (www.candidagenome.org),
or based on the function of their closest S. cerevisiae
homolog, according to the Saccharomyces Genome Database
(www.yeastgenome.org).
Disruption of the CgFLR1 and CgFLR2
Genes
The deletion of the C. glabrata FLR1 and FLR2 genes (ORFs
CAGL0H06017g and CAGL0H06039g, respectively) was carried
out in the parental strain KUE100, using the method described
by Ueno et al. (2011). The target genes CgFLR1 and CgFLR2
were replaced by a DNA cassette including the CgHIS3 gene,
through homologous recombination. The replacement cassette
was prepared by PCR using the primers 5′ AGAGAAAAA
TAAAACCAATTCTAAAACCAAATCCATATTACAACCCAA
TTGCAAAGGGCCGCTGATCACG-3′ and 5′-AATGTTAG
TGTGAACTTGAATGTTAGATTTTCACGTGAATGAGAA
CTGAGAAATCACATCGTGAGGCTGG-3′, for the CgFLR1
gene, and the primers 5′-AGAATCATATTCATAAAGGTAACA
AAACTACACAACAAATTATTAACTATTTTACAGGCCGCT
GATCACG-3′ and 5′-AAATAATTTGTTCGGGGTAAGCAC
AATTGGAGGCTCTATCTTTTTTCTCTTCTTCACATCGTG
AGGCTGG-3′, for the CgFLR2 gene. The pHIS906 plasmid
including CgHIS3 was used as a template and transformation
was performed as described previously (Ueno et al., 2007).
Recombination locus and gene deletion were verified by PCR
using the following pairs of primers: 5′-GAGGTGCTTAAT
ATCGTCAC -3′ and 5′-CAACAACGTGTCCTACATG-3′; and
5′-GTGCATTTCAGGACACACT-3′ and 5′-GTATTTGTTCTT
GTCCTGGTGTG -3′, respectively.
Cloning of the C. glabrata CgFLR1 and
CgFLR2 Genes (ORFs CAGL0H06017g and
CAGL0H06039g, Respectively)
The pGREG576 plasmid from the Drag & Drop collection was
used to clone and express the C. glabrata ORFs CAGL0H06017g
and CAGL0H06039g in S. cerevisiae, as described before for
other heterologous genes (Costa et al., 2013a,b, 2014b). CgFLR1
or CgFLR2 DNA was generated by PCR, using genomic DNA
extracted from the sequenced CBS138 C. glabrata strain, and the
following specific primers: 5′–GAATTCGATATCAAGCTTAT
CGATACCGTCGACAGCAAAGATGAATTATCTTC -3′ and
5′-GCGTGACATAACTAATTACATGACTCGAGGTCGACTC
ACCTGTTGTATTTAGACATGG -3′; or 5′-GAATTCGATATC
AAGCTTATCGATACCGTCGACAATGTATATCGGTGCA
TTTCAGGAC -3′ and 5′-GCGTGACATAACTAATTACAT
GACTCGAGGTCGACTCATGAATCTGGACTAAATCTTG
-3′, respectively. These plasmids include a S. cerevisiae CEN/ARS
element which had been shown before to work in C. glabrata
(Willins et al., 2002). The GAL1 promoter present in the
pGREG576_CgFLR1 and pGREG576_CgFLR2 plasmids
was then replaced by the copper-induced MTI C. glabrata
promoter, giving rise to the pGREG576_MTI_CgFLR1 and
pGREG576_MTI_CgFLR2 plasmids. The MTI promoter DNA
was generated by PCR, using genomic DNA extracted from
the sequenced CBS138 C. glabrata strain, and the following
specific primers: 5′-TTAACCCTCACTAAAGGGAACAAA
AGCTGGAGCTCTGTACGACACGCATCATGTGGCAATC
-3′ and 5′-GAAAAGTTCTTCTCCTTTACTCATACTAGT
GCGGCTGTGTTTGTTTTTGTATGTGTTTGTTG -3′. The
recombinant plasmids pGREG576_CgFLR1, pGREG576_
CgFLR2, pGREG576_MTI_CgFLR1, and pGREG576_MTI_
CgFLR2 were obtained through homologous recombination
in S. cerevisiae and verified by DNA sequencing. As before
(Costa et al., 2013a,b, 2014b), the transformation of L5U1 C.
glabrata cells with the pGREG576 plasmids, as well as plasmid
propagation was ensured by growth in selective uracil depleted
medium.
CgFlr1 and CgFlr2 Subcellular Localization
Assessment
The sub-cellular localization of the CgFlr1 and CgFlr2 proteins
was determined based on the observation of BY4741 S. cerevisiae
or L5U1 C. glabrata cells transformed with the pGREG576-
CgFLR1 and pGREG576-CgFLR2 or pGREG576-MTI-CgFLR1
and pGREG576-MTI-CgFLR2 plasmids, respectively. These cells
express the CgFlr1_GFP or CgFlr2_GFP fusion proteins, whose
localization may be determined using fluorescence microscopy.
S. cerevisiae cell suspensions were prepared by cultivation in BM-
U medium, containing 0.5% glucose and 0.1% galactose, at 30◦C,
with orbital shaking (250 rpm), until a standard culture OD600nm
= 0.4 ± 0.04 was reached. At this point cells were transferred
to the same medium containing 0.1% glucose and 1% galactose,
to induce protein expression. C. glabrata cell suspensions were
prepared in BM-U medium, until a standard culture OD600nm
= 0.4 ± 0.04 was reached, and transferred to the same
medium supplemented with 50µM CuSO4 (Sigma), to induce
the expression of the fusion protein. After 5 h of incubation,
the distribution of CgFlr1_GFP or CgFlr2_GFP fusion proteins
in S. cerevisiae or in C. glabrata living cells was detected by
fluorescence microscopy in a Zeiss Axioplan microscope (Carl
Zeiss MicroImaging), using excitation and emission wavelength
of 395 and 509 nm, respectively. Fluorescence images were
captured using a cooled CCD camera (Cool SNAPFX, Roper
Scientific Photometrics).
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Antifungal Susceptibility Assays
The susceptibility of the parental strain KUE100 toward toxic
concentrations of the selected drugs was compared to that of
the deletion mutants KUE100_∆cgflr1 and KUE100_∆cgflr2
by spot assays, using the steps described elsewhere (Costa et al.,
2013b). The ability of CgFLR1 and CgFLR2 gene expression to
increase wild-type resistance to the tested chemical stresses was
also examined in the URA3- strain L5U1 C. glabrata strain, using
the pGREG576_MTI_CgFLR1 and pGREG576_MTI_CgFLR2
centromeric plasmids. Additionally, the effect of CgFLR1,
and CgFLR2 expression in S. cerevisiae BY4741 wild-type
strain and BY4741_∆flr1 single deletion mutant was also
carried out as described elsewhere (Costa et al., 2013b).
The tested drugs included the following compounds, used
in the specified concentration ranges: the azole antifungal
drugs ketoconazole (10–60mg/L), fluconazole (75–250mg/L),
miconazole (0.10–0.50mg/L), tioconazole (0.2–0.9mg/L),
itraconazole (0.1–20mg/L), and clotrimazole (1–15mg/L), the
polyene antifungal drug amphotericin B (0.10–0.30mg/L), the
fluoropyrimidine 5-flucytosine (0.01–4mg/L) and the pesticide
mancozeb (0.5–2.5mg/L) (all from Sigma).
Drug Accumulation Assays
The internal accumulation of flucytosine or clotrimazole was
determined by calculating the ratio between the radiolabeled
compound measured within the yeast cells and in the
external medium (Intracellular/Extracellular). The parental
strain KUE100 and the mutant strains KUE100_∆cgflr1 and
KUE100_∆cgflr2 were grown in BM medium until mid-
exponential phase and harvested by filtration. Cells were
washed and resuspended in BM medium, to obtain dense cell
suspensions (OD600nm = 0.5 ± 0.1, equivalent to ∼ 1.57mg
(dry weight) mL−1). Readily, 0.1µM of 3H- flucytosine or 3H-
clotrimazole (American Radiolabelled Chemicals; 1mCi/ml) and
sub-inhibitory concentrations of the corresponding cold drug
were added to the cell suspensions. Incubation proceeded for
an additional period of 30 min. The intracellular accumulation
of labeled antifungal was followed by filtering 200µl of cell
suspension, at adequate time intervals, through pre-wetted glass
microfiber filters (Whatman GF/C). The filters were washed
with ice-cold TM buffer and the radioactivity measured in a
Beckman LS 5000TD scintillation counter. Extracellular 3H-
drug was estimated, by radioactivity assessment of 50µl of the
supernatant. Non-specific 3H-drug adsorption to the filters and
to the cells (<5% of the total radioactivity) was assessed and taken
into consideration. To calculate the intracellular concentration
of labeled antifungal drug, the internal cell volume (Vi) of
the exponential cells, grown in the absence of drug and used
for accumulation assays, was considered constant and equal to
2.5µl (mg dry weight)−1 (Rosa and Sá-Correia, 1996). Statistical
analysis of the results was performed using analysis of variance,
and differences were considered significant for P < 0.05.
CgFLR1 and CgFLR2 Expression
Measurements
The levels of CgFLR1 and CgFLR2 transcripts were assessed
by real-time PCR, using the approach described before (Costa
et al., 2013b). Synthesis of cDNA for real time RT-PCR
experiments, from total RNA samples, was performed using the
MultiscribeTM reverse transcriptase kit (Applied Biosystems) and
the 7500 RT-PCR Thermal Cycler Block (Applied Biosystems),
following the manufacturer’s instructions. The quantity of
cDNA for the following reactions was kept around 10 ng.
The subsequent RT-PCR step was carried out using SYBR R©
Green reagents. Primers for the amplification of the CgFLR1,
CgFLR2, and CgACT1 cDNA were designed using Primer
Express Software (Applied Biosystems) and are—TCTTATTCA
CGATGCTACAAATTGG -3′ and 5′-GAATCACAAGGCCAG
CAAAGTT -3′; 5′-GCAGCGGCATTCCCATTAT -3′ and 5′-
CGGGATACTTTTTTGTGCTCAAT -3′; and 5′-AGAGCCGTC
TTCCCTTCCAT -3′ and 5′-TTGACCCATACCGACCATGA -
3′, respectively. The RT-PCR reaction was carried out using a
thermal cycler block (7500 Real-Time PCR System—Applied
Biosystems). Default parameters established by the manufacturer
were used and fluorescence detected by the instrument and
registered in an amplification plot (7500 System SDS Software—
Applied Biosystems). The CgACT1 mRNA level was used
as an internal control. The relative values obtained for the
wild-type strain in control conditions were set as 1 and
the remaining values are presented relative to that control.
To avoid false positive signals, the absence of non-specific
amplification with the chosen primers was confirmed by the
generation of a dissociation curve for each pair of primers.
Statistical analysis of the results was performed using analysis
of variance, and differences were considered significant for
P < 0.05.
RESULTS
Membrane Proteome-Wide Changes
Occurring in Response to Flucytosine in
C. glabrata
Given the importance of membrane proteins as a
first line of defense against external stress agents, the
membrane proteome of C. glabrata cells exposed to
flucytosine-induced stress was compared to that of
unstressed cells. Details on the protein quantification
can be assessed at the Mass spectrometry Interactive
Virtual Environment (MassIVE) repository (https://
massive.ucsd.edu/ProteoSAFe/static/massive.jsp; MassIVE
ID: MSV000079209). Annotated spectra for single
peptide identification for each protein in the membrane-
associated proteome is provided in MS-viewer
(http://prospector2.ucsf.edu/prospector/cgi-bin/msform.cgi?for
m=msviewer; Search keys: qrvm65goix; xffxn22szm;
tm0y9x0hqd) (Pais et al., 2016).
Among the identified membrane-associated proteins,
32 were found to exhibit more than 1.5-fold increased or
decreased concentrations in C. glabrata cells exposed to
inhibitory concentrations of flucytosine, when compared to
the same cells growing in the absence of stress. Within these
proteins, 21 were found to be down-regulated and 11 up-
regulated in flucytosine challenged cells. Categorization of
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these proteins, based on their function predicted by homology
to their S. cerevisiae homologs, enabled their clustering
into seven groups: Glucose metabolism; Mitochondrial
function; Amino acid/Nucleotide metabolism; Ribosome
components and translation machinery; Lipid metabolism; Cell
wall assembly; Multidrug Resistance transporters (Figure 1;
Table 1).
The largest functional group identified in the 5-FC membrane
proteome response, including a third of the proteins with altered
content, is related to RNA metabolism. The expression of seven
proteins involved in ribosome biogenesis and translation was
found to increase in flucytosine stressed cells, whereas three
proteins of the same category were found to be down-regulated in
these conditions. It is difficult to say what the exact consequences
of the altered expression of each of them individually may be.
Additionally, the concentration of several proteins related to
glucose metabolism and mitochondrial function related proteins
was found to decrease in the presence of flucytosine. The
expression of one amino acid biosynthetic protein, Ilv5, and
two pyrimidine biosynthetic proteins, Ura1, and Ura3, was also
found to decrease in cells exposed to this antifungal agent.
Interestingly, Ura3 is responsible for the conversion of 5-FOA
into 5-fluorouracil, a key step in the conversion of flucytosine
into its toxic sub-products. The repressed expression of the
Ura proteins may confer an advantage to flucytosine stressed
cells as it may delay the conversion of this pro-drug into its
toxic subproducts. Finally, a group of five multidrug transporters
was found to exhibit altered levels of expression in flucytosine
stressed cells. Four of them, previously implicated in azole
drug resistance (Sanglard et al., 1999; Vermitsky et al., 2006;
Torelli et al., 2008; Costa et al., 2013b), were actually found
to be down-regulated, while the fifth, CgFlr1, was found to be
more than 2-fold up-regulated upon C. glabrata exposure to
flucytosine.
Effect of CgPDR1 Deletion in the
Membrane Proteome-Wide Changes
Occurring in Response to Flucytosine in
C. glabrata
To assess the possible involvement of the transcription factor
Pdr1 in the resistance to 5-flucytosine, the growth of the
C. glabrata strains 66032u and 66032u_∆cgpdr1 (Vermitsky
and Edlind, 2004) was compared in solid medium containing
inhibitory concentrations of flucytosine, clotrimazole and
fluconazole (Figure 2). CgPDR1 deletion fully abrogates growth
in the presence of the tested azole drug concentrations, as
expected based on numerous reports on the pivotal role of
this transcription factor in azole drug resistance. Interestingly,
the ∆cgpdr1 deletion mutant was also found to display higher
susceptibility to the antifungal drug 5-FC than the wild-type
parental strain, suggesting that it plays a role in the resistance
to this drug as well. Based on this result, the analysis of
the membrane-enriched fraction of the C. glabrata proteome
obtained from cells exposed to 5-flucytosine in the absence of
the transcription factor CgPdr1 was assessed and compared to
that of the C. glabrata wild-type cells exposed to 5-flucytosine.
Considering an at least 1.5-fold difference in protein expression
activation in wild-type vs.∆cgpdr1 cells exposed to 5-flucytosine,
nine proteins were found to be repressed by CgPdr1; while
eight proteins were found to be activated by CgPdr1 (Table 1).
The PDRE loci BCCRYYRGD, TCCRYGGA (Tsai et al., 2010),
TCCACGGA, and HYCCGTGGR (Paul et al., 2014), were
searched for in the promoters of the referred genes using the
PathoYeastract database (Monteiro et al., 2016). Interestingly,
considering these 17 proteins, at least one CgPdr1-binding site
is found in the promoter regions of nine genes, suggesting the
action of CgPdr1 in their expression may be direct. For the
remaining 15 proteins, no statistically significant change could
FIGURE 1 | Major functional groups found to have significant expression changes in the C. glabrata membrane-enriched proteome upon exposure to
5-flucytosine. Proteins with significant expression changes include glucose metabolism (5 proteins), mitochondrial function (5 proteins), aminoacid/nucleotide
metabolism (3 proteins), ribosome components and translation machinery (10 proteins), lipid metabolism (3 proteins), cell wall assembly (1 protein), and multidrug
resistance transporters (5 proteins).
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TABLE 1 | Set of 32 proteins found to have significant expression changes in C. glabrata wild-type cells in the presence of flucytosine and correspondent
fold changes in ∆cgpdr1 mutant cells upon exposure to the drug.
C. glabrata
protein (ORF)
name
S. cerevisiae
homolog
Description of the function of the C. glabrata protein or of its
S. cerevisiae homolog
Wild-type fold
change (upon
5-flucytosine stress)
∆cgpdr1 fold
change (upon
5-flucytosine stress)
GLUCOSE METABOLISM
CgPDC1
(CAGL0M07920g)
PDC1 Pyruvate decarboxylase, involved in pyruvate metabolism 0.54 0.39
CAGL0L01485g GSF2 Putative protein of the ER membrane involved in hexose transporter
secretion
0.60 0.43
CgPGK1
(CAGL0L07722g)
PGK1 Putative 3-phosphoglycerate kinase 0.20 0.63
CgFBA1
(CAGL0L02497g)
FBA1 Fructose-bisphosphate aldolase 0.58 0.47
CAGL0G06138g YCK1 S. cerevisiae ortholog encodes a palmitoylated plasma membrane-bound
casein kinase I isoform; functions in morphogenesis, endocytic trafficking,
and glucose sensing
0.44 0.90*
MITOCHONDRIAL FUNCTION
CgRIP1
(CAGL0I03190g)
RIP1 Putative ubiquinol-cytochrome C reductase iron-sulfur protein 1.68 0.28
CAGL0F04213g AAC2 S. cerevisiae ortholog encodes a major ADP/ATP carrier of the
mitochondrial inner membrane
0.64 1.00*
CAGL0C02695g MDM10 Ortholog(s) have role in establishment of mitochondrion localization,
mitochondrial outer membrane translocase complex assembly,
phospholipid transport, protein import into mitochondrial outer membrane
0.51 0.91*
CAGL0L06490g PHB2 Ortholog(s) have role in mitochondrion inheritance, negative regulation of
proteolysis, protein folding and replicative cell aging
0.63 0.85*
CAGL0M09713g YIM1 Putative protein involved in DNA damage response 0.24 0.48
AMINO ACID / NUCLEOTIDE METABOLISM
CgILV5
(CAGL0B03047g)
ILV5 Ketol-acid reducto-isomerase 0.50 0.70*
CgURA3
(CAGL0I03080g)
URA3 Orotidine 5’-phosphate decarboxylase, catalyzes a step in pyrimidine
biosynthesis; converts 5-FOA into 5-fluorouracil, a toxic compound
0.44 2.92
CAGL0M12881g URA1 Ortholog(s) have dihydroorotate oxidase (fumarate) activity, role in ’de
novo’ pyrimidine nucleobase biosynthetic process
0.26 2.62
RIBOSOME COMPONENTS AND TRANSLATION MACHINERY
CAGL0L03846g DBP2 Ortholog(s) have RNA-dependent ATPase activity and role in mRNA
catabolic process, nonsense-mediated decay, rRNA processing
3.94 2.15
CAGL0E03938g RPL4B S. cerevisiae ortholog encodes a ribosomal 60S subunit protein L13B 1.56 1.30*
CAGL0K07414g RPL20B S. cerevisiae ortholog encodes a ribosomal 60S subunit protein L20A 1.70 0.97*
CAGL0J03234g RPS24B Ortholog(s) have role in maturation of SSU-rRNA from tricistronic rRNA
transcript
1.52 1.05*
CAGL0K01859g NOP1 Ortholog(s) have mRNA binding, rRNA methyltransferase activity and role
in box C/D snoRNA 3’-end processing, rRNA methylation
1.64 0.86*
CAGL0I00792g RPS16A Ortholog(s) have role in maturation of SSU-rRNA from tricistronic rRNA
transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) and 90S preribosome
1.97 1.27*
CAGL0G01078g RPL26A Ortholog(s) have RNA binding, structural constituent of ribosome activity,
role in cytoplasmic translation and cytosolic large ribosomal subunit
1.78 1.37*
CAGL0E02013g RPL18A S. cerevisiae ortholog encodes a ribosomal 60S subunit protein L18A 0.59 0.48
CAGL0L06886g RPL13B S. cerevisiae ortholog encodes a ribosomal 60S subunit protein L13B 0.62 0.96*
CAGL0A03278g RPL19A S. cerevisiae ortholog encodes a ribosomal 60S subunit protein L19A 0.33 0.55
LIPID AND CELL WALL METABOLISM
CAGL0L03828g CYB5 Ortholog(s) have electron carrier activity, role in ergosterol biosynthetic
process
2.14 0.98*
CAGL0E03201g CHO2 Ortholog(s) have phosphatidylethanolamine N-methyltransferase activity,
role in phosphatidylcholine biosynthetic process
1.56 1.56
(Continued)
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TABLE 1 | Continued
C. glabrata
protein (ORF)
name
S. cerevisiae
homolog
Description of the function of the C. glabrata protein or of its
S. cerevisiae homolog
Wild-type fold
change (upon
5-flucytosine stress)
∆cgpdr1 fold
change (upon
5-flucytosine stress)
CAGL0M08206g YJL171c S. cerevisiae ortholog encodes a GPI-anchored cell wall protein of
unknown function; induced in response to cell wall damage
0.59 0.5
CgHFD1
(CAGL0K03509g)
HFD1 Putative mitochondrial fatty aldehyde dehydrogenase 0.29 0.24
MULTIDRUG RESISTANCE TRANSPORTERS
CgFLR1
(CAGL0H06017g)
FLR1 Multidrug transporter of the major facilitator superfamily; 2.08 1.89**
CgSNQ2
(CAGL0I04862g)
SNQ2 Predicted plasma membrane ATP-binding cassette (ABC) transporter,
putative transporter involved in multidrug resistance
0.61 0.75*
CgCDR1
(CAGL0M01760g)
PDR5 Multidrug transporter of ATP-binding cassette (ABC) superfamily, involved
in resistance to azoles
0.30 0.1
CgYOR1
(CAGL0G00242g)
YOR1 Putative ABC transporter involved in multidrug efflux 0.51 0.44
CgQDR2
(CAGL0G08624g)
QDR2 Drug:H+ antiporter of the Major Facilitator Superfamily, confers imidazole
drug resistance
0.57 0.31
The name of the proteins whose expression change was found to vary more than 1.5-fold in the ∆cgpdr1 mutant when compared to the wild-type is underlined. Protein description
and clustering was obtained from the Candida Genome Database (www.candidagenome.org) or, when completely uncharacterized, based on the role of their predicted S. cerevisiae
homologs, obtained from the Yeast Genome Database (www.yeastgenome.org). *Fold change value outside of the chosen cut-off intervals (0.67 < fold change < 1.5); **Fold change
quantification considered as not statistically significant (p > 0.05).
be detected in the current experiment. The proteins whose
expression was found to be higher in the wild-type strain
than in the ∆cgpdr1 deletion mutant include the multidrug
transporters CgCdr1 and CgQdr2, but also two proteins related
to mitochondrial function, CgCyb5 (ORF CAGL0L03828g) and
CgRip1 (ORF CAGL0I03190g), and four proteins involved in
RNA metabolism, CgDbp2 (ORF CAGL0L03846g), CgNop1
(ORF CAGL0K01859g), CgRpl20B (ORF CAGL0K07414g), and
CgRps16A (ORF CAGL0I00792g).
CgFlr1 and CgFlr2 Expression Confers
Resistance to Other Chemical Stress
Inducers
The involvement of CgFlr1 and CgFlr2 in antifungal drug
resistance was evaluated, through susceptibility assays,
considering a total of nine antifungal drugs of four different
families and one agricultural fungicide mancozeb. The results
obtained by screening the susceptibility phenotypes of ∆cgflr1
and ∆cgflr2 mutants, when compared to the wild-type strain,
reveal that CgFLR1 confers resistance to mancozeb, whereas
CgFLR2 confers resistance to azoles and amphotericin B
(Figure 3).
Both CgFLR1 and CgFLR2 were found to confer resistance to
flucytosine, although the effect of CgFLR2 is stronger (Figure 3).
The expression of CgFLR1-GFP or CgFLR2-GFP in the L5U1
C. glabrata wild-type strain, as verified by anti-GFP western
analysis (Figure S1), was concordantly found to increase C.
glabrata natural resistance toward the antifungal drugs to which
the deletion of each gene was found to lead to a susceptibility
phenotype (Figure 4).
Using S. cerevisiae as a heterologous expression system,
the effect of CgFLR1 and CgFLR2 expression on yeast drug
resistance was further investigated. When expressed in S.
cerevisiae, the CgFLR1 and CgFLR2 genes were found to rescue
the susceptibility phenotype exhibited by the S. cerevisiae ∆flr1
mutant against flucytosine and mancozeb, and azole drugs,
respectively (Figure 5).
CgFlr1 and CgFlr2 Are Localized to the
Plasma Membrane
Upon expression induction, C. glabrata cells harboring the
pGREG576_MTI_CgFLR1 and pGREG576_MTI_CgFLR2
plasmids were inspected by fluorescence microscopy. The
CgFlr1_GFP and CgFlr2_GFP fusion proteins were found to be
localized to the cell periphery (Figure 6). In a similar approach,
CgFlr1_GFP and CgFlr2_GFP were found to be localized to the
cell periphery when expressed heterologously in S. cerevisiae
(Figure 6). These results strongly suggest plasma membrane
localization for both CgFlr1 and CgFlr2.
CgFlr1 and CgFlr2 Reduce the Intracellular
Accumulation of Antifungal Drugs in
C. glabrata
Consistent with the observed susceptibility phenotypes, ∆cgflr1
and ∆cgflr2 deletion mutants were found to accumulate 2-fold
more radiolabeled flucytosine than the KUE100 parental strain
(Figures 7A,B).
Additionally, ∆cgflr2 mutant cells were found to accumulate
around 8-fold more radiolabelled clotrimazole than the
parental strain (Figure 8). These results strongly suggest
that CgFlr1 and CgFlr2 activities increase C. glabrata
resistance toward flucytosine, and in the case of CgFlr2
toward azoles, by reducing their accumulation in yeast
cells.
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FIGURE 2 | CgPdr1 confers resistance to flucytosine in C. glabrata cells. Comparison of the susceptibility to inhibitory concentrations of flucytosine,
clotrimazole and fluconazole, at the indicated concentrations, of the C. glabrata 66032u and 66032u_∆cgpdr1 strains, in BM plates by spot assays. The inocula were
prepared as described under “Materials and Methods.” Cell suspensions used to prepare the spots were 1:5 (b) and 1:25 (c) dilutions of the cells suspension used in
(a). The displayed images are representative of at least three independent experiments.
FIGURE 3 | CgFlr1 and CgFlr2 confer resistance to flucytosine in C. glabrata cells. Comparison of the susceptibility to inhibitory concentrations of several
chemical stress inducers, at the indicated concentrations, of the C. glabrata KUE100, KUE100_∆cgflr1 and KUE100_∆cgflr2 strains, in BM plates by spot assays.
The inocula were prepared as described under “Materials and Methods.” Cell suspensions used to prepare the spots were 1:5 (b) and 1:25 (c) dilutions of the cells
suspension used in (a). The displayed images are representative of at least three independent experiments.
CgFLR1 and CgFLR2 Transcript Levels Are
Up-Regulated under Antifungal Stress,
Their Basal Expression Being Controlled by
CgPdr1 and CgYap1 Transcription Factors
In order to evaluate whether or not the expression of CgFLR1
and CgFLR2 is affected upon drug exposure, quantitative RT-
PCR was used to study the effect of flucytosine, clotrimazole, and
mancozeb stress exposure in the transcript levels of these genes.
No up-regulation of CgFLR1 or CgFLR2 genes could be detected
in wild-type cells upon flucytosine exposure. Interestingly,
however, CgFLR1 was found to be up-regulated in mancozeb
exposed cells, whereas both CgFLR1 and CgFLR2 were found to
be up-regulated upon exposure to clotrimazole or fluconazole
stress, which is consistent with the role of CgFLR1 and CgFLR2 in
mancozeb and azole drug resistance, respectively (Figures 9A,B).
Additionally, given the fact that the transcription factor
CgPdr1 is the master regulator of azole drug resistance (Tsai
et al., 2006) and CgYap1 had been previously linked to the
control of CgFlr1 expression (Chen et al., 2007), the effect of
CgYap1 and CgPdr1 deletion in the control of the expression
of CgFLR1 and CgFLR2 was further evaluated. CgFLR1 and
CgFLR2 up-regulation, registered under clotrimazole exposure—
but not under fluconazole stress —, was found to be abrogated in
the absence of CgPDR1 (Figure 9B), while CgPdr1 and CgYap1
were found to control the basal expression of both CgFLR1 and
CgFLR2 (Figures 9A,B). As expected, based on the proteomics
data, none of the genes was found to be controlled by CgPdr1
in flucytosine exposed cells. Unexpectedly, the up-regulation
of CgFLR1, and CgFLR2 registered under mancozeb stress was
found not to be controlled by CgYap1. Indeed, in ∆cgyap1 cells
the mancozeb-induced up-regulation of these genes was found
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FIGURE 4 | CgFlr1 and CgFlr2 expression increases flucytosine resistance in C. glabrata cells. Comparison of the susceptibility to inhibitory concentrations
of several chemical stress inducers, at the indicated concentrations, of the C. glabrata L5U1 strain, harboring the pGREG576 cloning vector (v) or the
pGREG576_MTI_CgFLR1 or pGREG576_MTI_CgFLR2 plasmids, in BM-U plates (50µM CuSO4 supplemented) by spot assays. The inocula were prepared as
described under “Materials and Methods.” Cell suspensions used to prepare the spots were 1:5 (b) and 1:25 (c) dilutions of the cells suspension used in (a). The
displayed images are representative of at least three independent experiments.
FIGURE 5 | CgFlr1 and CgFlr2 confer resistance to antifungal drugs when heterologously expressed in S. cerevisiae cells. Comparison of the
susceptibility to inhibitory concentrations of several chemical stress inducers, at the indicated concentrations, of the S. cerevisiae BY4741 and BY4741_∆flr1 strains,
harboring the pGREG576 cloning vector (v) or the pGREG576_CgFLR1 of pGREG576_CgFLR2 plasmids, in BM-U plates by spot assays. The inocula were prepared
as described under “Materials and Methods.” Cell suspensions used to prepare the spots were 1:5 (b) and 1:25 (c) dilutions of the cells suspension used in (a). The
displayed images are representative of at least three independent experiments.
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FIGURE 6 | CgFlr1 and CgFlr2 are plasma membrane proteins. Fluorescence of exponential phase BY4741 S. cerevisiae and L5U1 C. glabrata cells, harboring
the expression plasmids pGREG576_CgFLR1 and pGREG576_CgFLR2 or pGREG576_MTI_CgFLR1, and pGREG576_MTI_CgFLR2, after galactose or
copper-induced recombinant protein production, respectively.
FIGURE 7 | CgFlr1 and CgFlr2 expression decreases the intracellular
accumulation of 3H-flucytosine. Time-course accumulation of radiolabeled
3H-flucytosine in KUE100 wild-type () and KUE100_∆cgflr1 () (A) and
KUE100 () and KUE100_∆cgflr2 () (B) strains, during cultivation in BM
liquid medium in the presence of sub-lethal concentrations of unlabeled
flucytosine. Accumulation values are the average of at least three independent
experiments. Errors bars represent the corresponding standard deviations. *p
< 0.05.
to be even stronger than that registered in the wild-type strain
(Figures 9A,B).
DISCUSSION
5-Flucytosine has fallen into disuse due to the rapid acquisition
of resistance by fungal pathogens and to its moderate toxicity
in humans, limiting the administration of higher dosages. The
identification of the mechanisms underlying these phenomena
is, thus, crucial to maintain the use of 5-FC as a therapeutic
option. In this work, the changes occurring at the membrane
FIGURE 8 | CgFlr2 expression decreases the intracellular accumulation
of 3H-clotrimazole. Time-course accumulation of radiolabeled
3H-clotrimazole in KUE100 wild-type () and KUE100_∆cgflr2 () strains,
during cultivation in BM liquid medium in the presence of sub-lethal
concentrations of unlabeled clotrimazole. Accumulation values are the average
of at least three independent experiments. Errors bars represent the
corresponding standard deviations. ***p < 0.001.
proteome level inC. glabrata cells exposed to 5-FCwere analyzed,
highlighting new mechanisms of resistance to this antifungal
drug.
One of the most interesting aspects of this work concerns
the identification of CgPdr1 transcription factor, a major factor
of resistance to azoles (Tsai et al., 2006), as a determinant
of 5-FC resistance. The deletion of CgPdr1 was consistently
found to decrease the activation of about 50% of the membrane
proteins found to be up-regulated in response to 5-FC. Among
the proteins whose expression was seen to be affect by CgPdr1
deletion are the multidrug eﬄux transporter encoding genes
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FIGURE 9 | CgFLR1 and CgFLR2 transcriptional control. Comparison of the variation of the CgFLR1 (A) and CgFLR2 (B) transcript levels in the 66032u C.
glabrata wild-type strain and in the derived 66032u_∆cgpdr1 deletion mutant; and in the 84u C. glabrata wild-type strain and in the derived 84u_∆cgyap1 deletion
mutant, before and after 1 h of exposure to 60mg/L clotrimazole, 80 mg/L fluconazole, 8mg/L flucytosine and 20mg/L mancozeb. The presented transcript levels
were obtained by quantitative RT-PCR and are relative CgFLR1/CgACT1 or CgFLR2/CgACT1 mRNA, relative to the values registered in the 66032 or 84u parental
strains in control conditions. The indicated values are averages of at least three independent experiments. Error bars represent the corresponding standard deviations.
*p < 0.05; **p < 0.01.
CgCDR1 and CgQDR2, but also CgRIP1, encoding a putative
ubiquinol-cytochrome C reductase iron-sulfur protein, which
were previously found to be controlled by this transcription
factor (Tsai et al., 2006; Vermitsky et al., 2006; Ferrari et al.,
2011; Costa et al., 2013b; Pais et al., 2016). New putative targets
of CgPdr1 up-regulated in the context of 5-FC response include
four proteins involved in RNA metabolism, CgDbp2, CgNop1,
CgRpl20B, and CgRps16A. Interestingly, the traditional targets of
CgPdr1, including the ABC drug eﬄux pumps CgCdr1, CgYor1,
and CgSnq2 are repressed in response to 5-FC, which suggests
that, although being active in the response to azoles and to 5-FC,
the action of Pdr1 at the level of transcriptional control appears to
be different. It will be interesting to test whether this differential
outcome of CgPdr1 activity is linked to differences in terms of
the conformation of this transcription factor, whose activation
is known to occur by the direct binding to the drug molecule
(Thakur et al., 2008). To gain a full view on the extension of the
participation of CgPdr1 in 5-FC response, however, it would be
necessary to conduct a transcriptomics study.
A large proportion of the 5-FC response was found to
be related to RNA and protein metabolism. Interestingly, an
increased expression of some ribosome and translation associated
proteins was observed, which may be related to the specific
mechanism of action of 5-FC. It is thus possible to assume
that the RNA- and protein-metabolism-related genes identified
herein as responding to 5-FC challenge may be involved in
counteracting its primary toxic action. Previous analyses of the
transcriptome-wide S. cerevisiae (Zhang et al., 2002) or Candida
albicans (Liu et al., 2005) response to 5-FC, also highlighted the
relevance of RNA metabolism in the response to this antifungal
drug. Indeed, Liu et al. found an up-regulation of several genes
involved in RNA metabolism and translation (Liu et al., 2005),
while Zhang and co-workers showed a down regulation of
a few ribosomal protein encoding genes in these conditions
(Zhang et al., 2002). It is also in agreement with a previous
chemogenomic analysis of the determinants of 5-FC resistance
in the model yeast S. cerevisiae, in which about one fourth of the
determinants of resistance to this drug were found to be related to
RNA and protein metabolism (Costa et al., 2015). It appears that
C. glabrata cells try to compensate, with the increased expression
of translation associated proteins, the detrimental effect that 5-FC
exerts in this process.
Another interesting feature of the proteomics response
includes the down-regulation of two nucleotide biosynthesis
related proteins, CgUra1 and CgUra3. CgUra1 catalyses the
synthesis of ororate from dihydroorotate, which is, then
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converted to oritidine-5-phosphate. CgUra3 catalyses the next
step of conversion of oritidine-5-phosphate to UMP, which is
funneled into the production of UDP and UTP, used for RNA
synthesis. This same pathway is used to process 5-FC into its toxic
products, including 5F-UDP, which upon incorporation in RNA
molecules inhibits protein synthesis. It appears, thus, that the cell
responds to 5-FC induced stress by decreasing the expression of
enzymes required for its conversion to toxic 5-FC products. It
is interesting to point out, in this context, that the expression
level of CgUra1 and CgUra3 in the ∆cgpdr1 deletion mutant is
much higher than in wild-type cells. The up-regulation of these
proteins in the ∆cgpdr1 background may underlie the increased
susceptibility to 5-FC exhibited by this deletion mutant, when
compared to the wild-type strain.
Among the results obtained from the membrane proteomics
analysis, the role of CgFlr1 and of its homolog CgFlr2, in 5-FC
response was further analyzed. Although the concentration of
CgFlr2 was not found to be increased in the membrane proteome
of C. glabrata cells, both CgFlr1, and CgFlr2 were found to confer
resistance to 5-FC, apparently due to their role in controlling
the levels of 5-FC accumulation within C. glabrata cells. The
fact that CgFlr2 is not up-regulated in 5-FC-exposed cells but
is required for C. glabrata resistance to this stress, although
unexpected, is consistent with the frequent observation that the
genes that are required for the resistance to a given stress are
not necessarily up-regulated in response to that stress (Teixeira
et al., 2011). Interestingly, CgFlr1 was further found to confer
resistance to mancozeb, while CgFlr2 was also found to confer
resistance to azoles and amphotericin B, placing this transporter
at the intersection of multiple antifungal resistance mechanisms.
These two transporters constitute, thus, two additional players
in the antifungal drug resistance phenomenon. Our group
had previously shown that the acquaglyceroporins CgFps1 and
CgFps2 (Costa et al., 2015), as well as the DHA transporters
CgAqr1 (Costa et al., 2013a) and CgTpo1_1 and CgTpo1_2
(Pais et al., 2016) are determinants of flucytosine resistance as
well, suggesting that 5-FC extrusion is an important mechanism
of resistance against this antifungal drug and showing this
phenomenon to be the consequence of the additive contribution
of several players.
The analysis of the expression of the CgFLR1 and CgFLR2
genes further highlighted their importance in the context of
drug resistance in C. glabrata. Using the PathoYeastract database
(http://pathoyeastract.org/cglabrata/index.php Monteiro et al.,
2016), it is possible to verify that the CgFLR1 was found to be
up-regulated upon the over-expression of CgPdr1, in control
conditions (Noble et al., 2013), or upon benomyl or selenite
exposure, in the dependency of CgYap1 (Chen et al., 2007;
Lelandais et al., 2008; Merhej et al., 2016). Additionally, CgFLR1
expression was shown to be repressed by the transcription factor
Stb5, a negative regulator of azole resistance in C. glabrata (Noble
et al., 2013). Chromatine ImmunoPrecipitation (ChIP) assays
further showed that Yap7 binds to the CgFLR1 promoter in
selenite exposed cells (Merhej et al., 2016). Information on the
regulation of CgFLR2 is much scarcer. RNA sequencing data
have demonstrated that the predicted zinc cluster transcription
factor encoded by ORF CAGL0I07755g, a homolog of the S.
cerevisiae Hal9 and of the C. albicans Tac1 transcription factors,
is a positive regulator of CgFLR2 in control conditions (Wu
et al., 2015). The new data on the regulation of the CgFLR1
and CgFLR2 genes coming from this study shows that both
genes are controlled at the transcription level by CgPdr1 in the
presence of the azole drug clotrimazole, but not in the presence
of fluconazole. The fact that in previous genome-wide expression
analysis of fluconazole response in C. glabrata the regulation of
CgFLR1 or CgFLR2 by CgPdr1 had not been identified suggests
that this effect may be specific to imidazole antifungals, such as
clotrimazole, but not to triazole antifungals such as fluconazole.
Despite the fact that a previous ChIP experiment probing CgPdr1
targets in ρ0 C. glabrata cells did not pinpoint CgFLR1 or
CgFLR2 promoters as targets of CgPdr1 (Paul et al., 2014), a
putative CgPdr1 binding site can be found in the promoter
region of CgFLR2. The possibility, however, that CgPdr1 may
regulate the expression of CgFLR1 and CgFLR2 in clotrimazole
stressed cells through direct binding to their promoter regions
remains to be established. Given the importance of CgPdr1 in the
clinical acquisition of azole drug resistance, these results raise the
hypothesis that CgFlr1 and CgFlr2 may be relevant in the clinical
context. In a previous transcriptomics analysis of the impact
of CgPdr1 GOF mutations in fluconazole resistant isolates,
when compared to susceptible ones, no significant changes were
detected in terms of the expression of CgFLR1 or CgFLR2 (Tsai
et al., 2010). However, it would indeed be interesting to assess
whether there is a possible correlation between the expression of
these genes and the level of antifungal drug resistance in clinical
isolates displaying differential clotrimazole or 5-FC susceptibility
phenotypes. Additionally, the fact that the transcript levels of
both CgFLR1 and CgFLR2 genes is controlled, at least at the
basal level, by CgPdr1 and CgYap1, appears to correlate with
the complex regulation of their S. cerevisiae homolog Flr1. The
observation that S. cerevisiae FLR1 gene is also strongly up-
regulated by the transcription factor Yap1 in mancozeb stressed
cells (Teixeira et al., 2008) urged us to check for a similar effect
in C. glabrata CgFLR1 and CgFLR2 genes. However, although
an increased expression of CgFLR1 and CgFLR2 was indeed
registered in C. glabrata cells exposed to mancozeb, this proved
to be irrespective of CgYap1 activity, suggesting that the control
of the expression of these genes is not fully conserved in C.
glabrata. The transcriptional control of ScFlr1 was found to be
highly complex, relying on the combined efforts of at least four
transcription factors, Yap1, Pdr1, Yrr1, and Rpn4 (Alarco et al.,
1997; Brôco et al., 1999; Teixeira et al., 2008). The building of a
mathematical model to describe the ScFlr1 regulatory network
highlighted that this network is likely to require a fifth, still
unidentified, transcription factor to explain the experimental
observations, putting forward the hypothesis that its regulation
may be even more complex than initially foreseen (Teixeira
et al., 2010; Monteiro et al., 2011). It would be interesting to
check whether the homologs in C. glabrata of these additional
S. cerevisiae transcription factors may also be important in
the regulation of these genes, whose control appears to be
phylogenetically conserved among these yeast species.
In conclusion, the results described in this study highlight
the importance of the DHA transporters from the MFS in
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antifungal resistance. This work highlights the importance of
proteome-wide approaches in the identification of new antifungal
resistance mechanisms. The newly identified processes stand out
as promising targets for the development of new 5-flucytosine
chemosensitizers, which would expectedly allow for the use of
decreased therapeutic dosages of 5-flucytosine.
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Figure S1 | CgFlr1 and CgFlr2 are expressed in C. glabrata cells harboring
the pGREG576_MT1_CgFLR1 and the pGREG576_MT1_CgFLR2 plasmids.
Comparison of the level of expression of CgFlr1-GFP or CgFlr2-GFP fusion
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were used as a negative control.
REFERENCES
Alarco, A. M., Balan, I., Talibi, D., Mainville, N., and Raymond, M. (1997).
AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1
encoding a transporter of the major facilitator superfamily. J. Biol. Chem. 272,
19304–19313. doi: 10.1074/jbc.272.31.19304
Alarco, A. M., and Raymond, M. (1999). The bZip transcription factor Cap1p
is involved in multidrug resistance and oxidative stress response in Candida
albicans. J. Bacteriol. 181, 700–708.
Brôco, N., Tenreiro, S., Viegas, C. A., and Sá-Correia, I. (1999). FLR1 gene
(ORF YBR008c) is required for benomyl and methotrexate resistance
in Saccharomyces cerevisiae and its benomyl-induced expression is
dependent on Pdr3 transcriptional regulator. Yeast 15, 1595–1608.
doi: 10.1002/(SICI)1097-0061(199911)15:15<1595::AID-YEA484>3.0.
CO;2-6
Chen, K. H., Miyazaki, T., Tsai, H. F., and Bennett, J. E. (2007). The bZip
transcription factor Cgap1p is involved in multidrug resistance and required
for activation of multidrug transporter gene CgFLR1 in Candida glabrata. Gene
386, 63–72. doi: 10.1016/j.gene.2006.08.010
Costa, C., Dias, P. J., Sá-Correia, I., and Teixeira, M.C. (2014a). MFS multidrug
transporters in pathogenic fungi: do they have real clinical impact? Front.
Physiol. 5:197. doi: 10.3389/fphys.2014.00197
Costa, C., Henriques, A., Pires, C., Nunes, J., Ohno, M., Chibana, H., et al.
(2013a). The dual role of Candida glabrata drug:H+ antiporter CgAqr1 (ORF
CAGL0J09944g) in antifungal drug and acetic acid resistance. Front. Microbiol.
4:170. doi: 10.3389/fmicb.2013.00170
Costa, C., Nunes, J., Henriques, A., Mira, N. P., Nakayama, H., Chibana, H., et al.
(2014b). Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g):
role in azole drug resistance and polyamine homeostasis. J. Antimicrob.
Chemother. 69, 1767–1776. doi: 10.1093/jac/dku044
Costa, C., Pires, C., Cabrito, T. R., Renaudin, A., Ohno, M., Chibana, H.,
et al. (2013b). Candida glabrata drug:H+ antiporter CgQdr2 confers
imidazole drug resistance, being activated by transcription factor CgPdr1.
Antimicrob. Agents Chemother. 57, 3159–3167. doi: 10.1128/AAC.008
11-12
Costa, C., Ponte, A., Pais, P., Santos, R., Cavalheiro, M., Yaguchi, T., et al.
(2015). New Mechanisms of Flucytosine Resistance in C. glabrata Unveiled
by a Chemogenomics Analysis in S. cerevisiae. PLoS ONE 10:e0135110.
doi: 10.1371/journal.pone.0135110
Dos Santos, S. C., Teixeira, M. C., Dias, P. J., and Sá-Correia, I. (2014).
MFS transporters required for multidrug/multixenobiotic (MD/MX) resistance
in the model yeast: understanding their physiological function through
post-genomic approaches. Front. Physiol. 5:180. doi: 10.3389/fphys.2014.
00180
Edlind, T. D., and Katiyar, S. K. (2010). Mutational analysis of flucytosine
resistance in Candida glabrata. Antimicrob. Agents Chemother. 54, 4733–4738.
doi: 10.1128/AAC.00605-10
Espinel-Ingroff, A. (2008). Mechanisms of resistance to antifungal agents:
yeasts and filamentous fungi. Rev. Iberoam Micol. 25, 101–106.
doi: 10.1016/S1130-1406(08)70027-5
Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., and Sanglard,
D. (2011). Contribution of CgPDR1-regulated genes in enhanced
virulence of azole-resistant Candida glabrata. PLoS ONE 6:e17589.
doi: 10.1371/journal.pone.0017589
Fidel, P. L. Jr., Vazquez, J. A., and Sobel, J. D. (1999). Candida glabrata: review
of epidemiology, pathogenesis, and clinical disease with comparison to C.
albicans. Clin. Microbiol. Rev. 12, 80–96.
Gbelska, Y., Krijger, J. J., and Breunig, K. D. (2006). Evolution of gene families: the
multidrug resistance transporter genes in five related yeast species. FEMS Yeast
Res. 6, 345–355. doi: 10.1111/j.1567-1364.2006.00058.x
Ghannoum, M. A., and Rice, L. B. (1999). Antifungal agents: mode of action,
mechanisms of resistance, and correlation of these mechanisms with bacterial
resistance. Clin. Microbiol. Rev. 12, 501–517.
Hope, W. W., Tabernero, L., Denning, D. W., and Anderson, M. J.
(2004). Molecular mechanisms of primary resistance to flucytosine
in Candida albicans. Antimicrob. Agents Chemother. 48, 4377–4386.
doi: 10.1128/AAC.48.11.4377-4386.2004
Jansen, G., Wu, C., Schade, B., Thomas, D. Y., and Whiteway, M. (2005).
Drag&Drop cloning in yeast. Gene 344, 43–51. doi: 10.1016/j.gene.2004.
10.016
Frontiers in Microbiology | www.frontiersin.org 13 December 2016 | Volume 7 | Article 2045
Pais et al. Membrane Proteome-Wide Flucytosine Response in C. glabrata
Kontoyiannis, D. P., and Lewis, R. E. (2002). Antifungal drug resistance of
pathogenic fungi. Lancet 359, 1135–1144. doi: 10.1016/S0140-6736(02)08
162-X
Lelandais, G., Tanty, V., Geneix, C., Etchebest, C., Jacq, C., and Devaux, F. (2008).
Genome adaptation to chemical stress: clues from comparative transcriptomics
in Saccharomyces cerevisiae and Candida glabrata. Genome Biol. 9:R164.
doi: 10.1186/gb-2008-9-11-r164
Liu, T. T., Lee, R. E., Barker, K. S., Wei, L., Homayouni, R., and Rogers,
P. D. (2005). Genome-wide expression profiling of the response to
azole, polyene, echinocandin, and pyrimidine antifungal agents in
Candida albicans. Antimicrob. Agents Chemother. 49, 2226–2236.
doi: 10.1128/AAC.49.6.2226-2236.2005
Merhej, J., Thiebaut, A., Blugeon, C., Pouch, J., Ali Chaouche Mel, A., Camadro,
J. M., et al. (2016). A network of paralogous stress response transcription
factors in the human pathogen Candida glabrata. Front. Microbiol. 7:645.
doi: 10.3389/fmicb.2016.00645
Mishra, N. N., Prasad, T., Sharma, N., Payasi, A., Prasad, R., Gupta, D. K.,
et al. (2007). Pathogenicity and drug resistance in Candida albicans and
other yeast species. A review. Acta Microbiol. Immunol. Hung 54, 201–235.
doi: 10.1556/AMicr.54.2007.3.1
Monteiro, P. T., Dias, P. J., Ropers, D., Oliveira, A. L., Sá-Correia, I., and Freitas,
A. T. (2011). Qualitative modeling and formal verification of the FLR1 gene
mancozeb response in Saccharomyces cerevisiae. IET Syst. Biol. 5, 308–316.
doi: 10.1049/iet-syb.2011.0001
Monteiro, P. T., Pais, P., Costa, C., Manna, S., Sa-Correia, I., and Teixeira, M. C.
(2016). The PathoYeastract database: an information system for the analysis of
gene and genomic transcription regulation in pathogenic yeasts. Nucleic Acids
Res. doi: 10.1093/nar/gkw817. [Epub ahead of print].
Noble, J. A., Tsai, H. F., Suffis, S. D., Su, Q., Myers, T. G., and Bennett, J. E. (2013).
STB5 is a negative regulator of azole resistance inCandida glabrata.Antimicrob.
Agents Chemother. 57, 959–967. doi: 10.1128/AAC.01278-12
Pais, P., Costa, C., Pires, C., Shimizu, K., Chibana, H., and Teixeira, M. C. (2016).
Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in
Candida glabrata: role of the transcription factor CgPdr1 and the Drug:H+
Antiporters CgTpo1_1 and CgTpo1_2. Mol. Cell. Proteomics 15, 57–72.
doi: 10.1074/mcp.M114.045344
Papon, N., Nöel, T., Florent, M., Gibot-Leclerc, S., Jean, D., Chastin, C., et al.
(2007). Molecular mechanism of flucytosine resistance in Candida lusitaniae:
contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and
fluconazole cross-resistance. Antimicrob. Agents Chemother. 51, 369–371.
doi: 10.1128/AAC.00824-06
Paul, S., Bair, T. B., and Moye-Rowley, W. S. (2014). Identification of
genomic binding sites for Candida glabrata Pdr1 transcription factor in
wild-type and rho0 cells. Antimicrob. Agents Chemother. 58, 6904–6912.
doi: 10.1128/AAC.03921-14
Rosa, M. F., and Sá-Correia, I. (1996). Intracellular acidification does not account
for inhibition of Saccharomyces cerevisiae growth in the presence of ethanol.
FEMS Microbiol. Lett. 135, 271–274. doi: 10.1111/j.1574-6968.1996.tb08000.x,
Sá-Correia, I., dos Santos, S. C., Teixeira, M. C., Cabrito, T. R., and Mira, N.
P. (2009). Drug:H+ antiporters in chemical stress response in yeast. Trends
Microbiol. 17, 22–31. doi: 10.1016/j.tim.2008.09.007
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., and Bille, J. (1999).
The ATP binding cassette transporter gene CgCDR1 from Candida glabrata
is involved in the resistance of clinical isolates to azole antifungal agents.
Antimicrob. Agents Chemother. 43, 2753–2765.
Sanglard, D., and Odds, F. C. (2002). Resistance of Candida species to antifungal
agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2,
73–85. doi: 10.1016/S1473-3099(02)00181-0
Teixeira, M. C., Dias, P. J., Monteiro, P. T., Sala, A., Oliveira, A. L., Freitas, A. T.,
et al. (2010). Refining current knowledge on the yeast FLR1 regulatory network
by combined experimental and computational approaches. Mol. Biosyst. 6,
2471–2481. doi: 10.1039/c004881j
Teixeira, M. C., Dias, P. J., Simões, T., and Sá-Correia, I. (2008). Yeast adaptation
to mancozeb involves the up-regulation of FLR1 under the coordinate control
of Yap1, Rpn4, Pdr3, and Yrr1. Biochem. Biophys. Res. Commun. 367, 249–255.
doi: 10.1016/j.bbrc.2007.12.056
Teixeira, M. C., Mira, N. P., and Sá-Correia, I. (2011). A genome-wide
perspective on the response and tolerance to food-relevant stresses
in Saccharomyces cerevisiae. Curr. Opin. Biotechnol. 22, 150–156.
doi: 10.1016/j.copbio.2010.10.011
Thakur, J. K., Arthanari, H., Yang, F., Pan, S. J., Fan, X., Breger, J., et al. (2008). A
nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature
452, 604–609. doi: 10.1038/nature06836
Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D.,
et al. (2008). The ATP-binding cassette transporter-encoding gene CgSNQ2 is
contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
Mol. Microbiol. 68, 186–201. doi: 10.1111/j.1365-2958.2008.06143.x
Tsai, H. F., Krol, A. A., Sarti, K. E., and Bennett, J. E. (2006). Candida glabrata
PDR1, a transcriptional regulator of a pleiotropic drug resistance network,
mediates azole resistance in clinical isolates and petite mutants. Antimicrob.
Agents Chemother. 50, 1384–1392. doi: 10.1128/AAC.50.4.1384-1392.2006
Tsai, H. F., Sammons, L. R., Zhang, X., Suffis, S. D., Su, Q., Myers, T. G., et al.
(2010). Microarray and molecular analysis of the azole resistance mechanism
in Candida glabrata oropharyngeal isolates. Antimicrob. Agents Chemother. 54,
3308–3317, doi: 10.1128/AAC.00535-10
Ueno, K., Matsumoto, Y., Uno, J., Sasamoto, K., Sekimizu, K., Kinjo, Y.,
et al. (2011). Intestinal resident yeast Candida glabrata requires Cyb2p-
mediated lactate assimilation to adapt in mouse intestine. PLoS ONE 6:e24759.
doi: 10.1371/journal.pone.0024759
Ueno, K., Uno, J., Nakayama, H., Sasamoto, K., Mikami, Y., and Chibana, H.
(2007). Development of a highly efficient gene targeting system induced by
transient repression of YKU80 expression in Candida glabrata. Eukaryotic Cell
6, 1239–1247. doi: 10.1128/EC.00414-06
Vermes, A., Guchelaar, H. J., and Dankert, J. (2000). Flucytosine: a review of
its pharmacology, clinical indications, pharmacokinetics, toxicity and drug
interactions. J. Antimicrob. Chemother. 46, 171–179. doi: 10.1093/jac/46.
2.171
Vermitsky, J. P., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D.,
and Rogers, P. D. (2006). Pdr1 regulates multidrug resistance in Candida
glabrata: gene disruption and genome-wide expression studies.Mol. Microbiol.
61, 704–722. doi: 10.1111/j.1365-2958.2006.05235.x
Vermitsky, J. P., and Edlind, T. D. (2004). Azole resistance in Candida glabrata:
coordinate upregulation of multidrug transporters and evidence for a Pdr1-
like transcription factor. Antimicrob. Agents Chemother. 48, 3773–3781.
doi: 10.1128/AAC.48.10.3773-3781.2004
White, T. C. (1997). Increased mRNA levels of ERG16, CDR, and MDR1 correlate
with increases in azole resistance in Candida albicans isolates from a patient
infected with human immunodeficiency virus. Antimicrob. Agents Chemother.
41, 1482–1487.
Willins, D. A., Shimer, G. H. Jr., and Cottarel, G. (2002). A system for
deletion and complementation of Candida glabrata genes amenable to high-
throughput application. Gene 292, 141–149. doi: 10.1016/S0378-1119(02)00
648-0
Wu, J., Chen, X., Cai, L., Tang, L., and Liu, L. (2015). Transcription factors Asg1p
and Hal9p regulate pH homeostasis in Candida glabrata. Front. Microbiol.
6:843. doi: 10.3389/fmicb.2015.00843
Zhang, L., Zhang, Y., Zhou, Y., Zhao, Y., and Cheng, J. (2002). Expression
profiling of the response of Saccharomyces cerevisiae to 5-fluorocytosine
using a DNA microarray. Int. J. Antimicrob. Agents 20, 444–450.
doi: 10.1016/S0924-8579(02)00201-7
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Pais, Pires, Costa, Okamoto, Chibana and Teixeira. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 14 December 2016 | Volume 7 | Article 2045
